EN
AR
BG
HR
CS
DA
NL
FI
FR
DE
EL
HI
IT
JA
KO
NO
PL
PT
RO
RU
ES
SV
TL
IW
ID
LV
LT
SR
SK
VI
HU
TH
TR
GA
CY
KA
LA
MN
KK
LB
2-Deoxy-2,2-difluoro-D-erythro-pentafuranous-1-ulose-3,5-dibenzoas CAS 122111-01-7
Nomen Chemicum : 2-Deoxy-2,2-difluoro-D-erythro-pentafuranosus-1-ulose-3,5-dibenzoas
Synonyma nomina :2-Deoxy-2,2-difluoro-D-erythro-pentofuranosus-1-ulose-3,5-dibenzoas; 2-Deoxy-2,2-difluoro-D-erythro-pentonica acidus γ-lactonum 3,5-dibenzoas; (2R,3R)-4,4-Difluor-5-oxo-2-{[(phenylcarbonyl)oxy]methyl}tetrahydrofuran-3-ylbenzolcarboxylat (nomen non praefertur)
CAS No :122111-01-7
Formula moleculare :C19H14F2O6
Pondus Moleculare :376.31
EINECS NON :601-822-8
- Parametrum
- Producta Relata
- Inquisitio
Formulae structurales ：
Productum Descriptio ：
|
Items |
Specifications |
|
Apparentia |
Pulvis coloris albae |
|
Pertentare,% |
99.0MIN |
|
Liquefactio Point |
117-119 °C (lit.) |
|
Punctum ebullitionis |
437.2±45.0 °C (Predicted) |
|
Densitas |
1.41±0.1 g/cm3 (Praedictum) |
Properties and Usus :
2-Deoxy-2,2-difluoro-D-erythro-pentafuranosus-1-ulose-3,5-dibenzoas, quod etiam notatur ut D-erythro-Pentonica acidum, est compositum organum continens fluorinum.
1. Medicamentorum elaboratio: usum habet in elaboratione medicamentorum antiviralium et anticancerosis, et ut intermediarius clavis ad medicamenta contra cancer, sicut gemcitabine.
2. Chimia nucleica: usum habet ad elaborandum moleculas modificatas DNA/RNA et technologias notationis biologicarum cum stabilitate et specificitate auctis.
3. Synthesis organica et modus structurae: ut intermediarius clavis, usum habet ad aedificanda moleculas continentes fluorinum et ad studendum inhibatores enzymorum et stabilitatem metabolicae.
4. Biochemica investigatio: agit partem magnam in studio de modificatione metabolica saccharorum et mecanismo actionis target biologici.
Condiciones reconditae: Sigillatum in arido, Conservare in congelatore, sub -20°C
Stipare: Productum hoc in tympanis 25kg cardboard refertum est, et potest etiam nativus secundum exigentias clientium
